Drug reviews

Three positions were issued on drug reviews:

• Legal position of the Legal Office of the Supreme Pharmaceutical Chamber.
• Position of Coordinators of the National Drug Review Pilot.
• The position of the President of the Supreme Pharmaceutical Court (NSA) and the Supreme Professional Liability Officer (NROZ).

There are two conclusions in the position of the Supreme Pharmaceutical Chamber:

1. As a rule, every pharmacist qualified to practice as a pharmacist is entitled to provide pharmaceutical care, which is the basic form of practicing the profession of pharmacist.
2. Additional requirements for pharmacists have been laid down for some healthcare services within the scope of pharmaceutical care.

Certain simple services are subject to completion of a certain course. This applies to vaccinations and diagnostic tests. There is no doubt that performing drug reviews is the most difficult and complicated service, because it requires appropriate preparation in the field of: interview collecting, thorough analysis of patients' various drug situations, preparation of appropriate recommendations and undertaking substantive clinical discussions with a physician. Since the performance of a simple service requires the completion of a course, it is obvious that in order to be able to perform drug reviews, an appropriate course must be completed.

In the Position of Coordinators, it was emphasized that the performance of drug reviews is a new competence that requires additional qualifications. The key element is the standardization of the drug review as it must be performed at a very high level. Drug reviews must be carried out with the highest diligence and quality of the process. The coordinators end their position with the sentence: "In the interests of the patients' well-being, we ask all Pharmacists and Employers to be careful about conducting a drug review.

On September 9, 2022, the Position of the Chairperson of the Supreme Administrative Court and NROZ was issued, which includes the following statement: o currently binding legal regulations. " The position is unnecessary and groundless as the Supreme Administrative Court and the NROZ are not parties to the present case. It is worth recalling how the NROZ and the Supreme Administrative Court examined the case of a pharmacist from Rzeszów, who offered pharmaceutical advice (care) on Allegro, informing that the advice was provided by a Provincial Consultant from a pharmacy pharmacy and a Member of the Supreme Pharmaceutical Court. It should be emphasized that the Podkarpackie Voivode dismissed the pharmacist from the position of the Provincial Consultant for breaking the law. NROZ issued a decision to discontinue the investigation, while the Supreme Administrative Court issued a decision dismissing the complaint. This NROZ and NSA behavior is extremely irresponsible because it is a bit like mafia behavior: we protect our man despite breaking the law.

During the epidemic in Poland (from March 20, 2020 to May 16, 2022), 1,674 pharmacists issued 6,621 pharmaceutical prescriptions for the drug amantadine. It is worth pointing out that there is no scientific evidence or evidence that amantadine can be effective in treating COVID-19. It is known that amantadine enthusiasts did not get vaccinated because they were taking the drug. They were then hospitalized in a serious condition and died of COVID-19. It should be emphasized that the NRA and NROZ did nothing despite the fact that the matter is deadly serious in the literal sense of the word. Will pharmacists who prescribe amantadine also review their medications? The mere thought of it makes you fear to be afraid.

NRA, NROZ and the President of the Supreme Administrative Court do not understand that every pharmacist should be a guarantor of safe pharmacotherapy. Coordinators of the National Drug Review Pilot perfectly understand that pharmacists should guarantee safe pharmacotherapy.

MA farm. Walenty Zajdel